As of November 2024, Taiwan Advance Bio-Pharmaceutical has a market cap of $45.16M. This makes Taiwan Advance Bio-Pharmaceutical the world's 25782th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $42.49M | -10.91% |
2023 | $47.70M | -1.45% |
2022 | $48.40M | -6.78% |
2021 | $51.92M | -27.22% |
2020 | $71.33M | 36.00% |
2019 | $52.45M | -6.75% |
2018 | $56.25M | 6.30% |
2017 | $52.92M | -24.38% |
2016 | $69.98M | -32.34% |
2015 | $103.44M | -13.77% |
2014 | $119.95M | -27.78% |
2013 | $166.08M | -2.36% |
2012 | $170.09M | - |